244 results
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
21 Mar 06
Sanofi-aventis and Bristol-myers Squibb Announce
12:00am
of exclusivity.
Q6.
What do you think about the prospects for obtaining FTC and state attorneys general antitrust review and clearance?
A6
As we said … in the release, there is a significant risk that the required antitrust clearance will not be obtained.
Q7.
What is the process for obtaining antitrust
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
3 Feb 03
Other events
12:00am
------------------- ---------------------
BRISTOL-MYERS SQUIBB TO SETTLE ANTITRUST LITIGATION
NEW YORK, N.Y. (January 7, 2003) - Bristol-Myers Squibb Company (NYSE:BMY)
today … announced that it has reached agreements in principle that would settle
substantially all antitrust litigation surrounding two of its products
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
21 Mar 06
Sanofi-aventis and Bristol-myers Squibb Announce
12:00am
is subject to certain conditions, including antitrust review and clearance by the Federal Trade Commission and state attorneys general … . There is a significant risk that required antitrust clearance will not be obtained. In such event, the proposed settlement would be terminated, and the litigation
SC TO-T/A
9si5c r3cubg
19 Jul 22
Third party tender offer statement (amended)
7:13am
SC TO-T/A
d468amjz369dqju
16 Aug 22
Third party tender offer statement (amended)
7:08am
SC TO-T/A
jj2rt8fmfbruffgkb
12 Feb 24
Third party tender offer statement (amended)
7:34am
SC TO-T
EX-99
m1kzvkjk05hci42
17 Jun 22
Third party tender offer statement
4:42pm
8-K
tf3sttw
21 Mar 06
Sanofi-aventis and Bristol-myers Squibb Announce
12:00am
SC TO-T
EX-99
kx2siczqpvh56l kx
17 Jun 22
Third party tender offer statement
4:42pm
SC TO-T
EX-99
pmxwowhy
17 Jun 22
Third party tender offer statement
4:42pm
SC TO-T
EX-99
uwtrtcg4tjnovst
17 Jun 22
Third party tender offer statement
4:42pm
SC TO-T
EX-99
al6wvqj2i60 gu
13 Jan 12
Third party tender offer statement
12:00am